Vivos Therapeutics Inc Financial Flexibility Index
Vivos Therapeutics Inc financial flexibility index. Vivos Therapeutics Inc (VVOS) has a Financial Flexibility Index of -0.11x as of June 2026. Free cash flow of $-3.13 Million (operating CF $-3.15 Million minus capex $18.00K) represents 0% of total liabilities ($28.13 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Vivos Therapeutics Inc (2018–2025)
Financial flexibility index of Vivos Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Vivos Therapeutics Inc across 8 annual periods. Explore Vivos Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Vivos Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Vivos Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Vivos Therapeutics Inc. For the full cash flow conversion analysis, see VVOS cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | $-12.92 Million | $-15.26 Million | $26.70 Million | ▲ +70.7% |
| 2024 | -1.65x | $-12.12 Million | $-12.69 Million | $7.33 Million | ▼ -53.2% |
| 2023 | -1.08x | $-11.14 Million | $-11.95 Million | $10.32 Million | ▲ +48.4% |
| 2022 | -2.09x | $-18.66 Million | $-19.59 Million | $8.92 Million | ▼ -27.8% |
| 2021 | -1.64x | $-13.34 Million | $-15.73 Million | $8.15 Million | ▼ -147.6% |
| 2020 | -0.66x | $-5.56 Million | $-5.68 Million | $8.41 Million | ▼ -34.3% |
| 2019 | -0.49x | $-5.16 Million | $-5.34 Million | $10.49 Million | ▲ +59.1% |
| 2018 | -1.20x | $-4.06 Million | $-5.31 Million | $3.38 Million | — |